United States Biotechnology & Medical Research

Axovant Gene Therapies Ltd (AXGT)

Track

Track

Ticker: AXGT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Cheruvu Pavan Chief Executive Officer Executive Director
Transaction date
Purchase
Price
318.60
Quantity 10,237 +38.6%
Value US$3,746,058
3.4
Pande Atul Non-Executive Director
Transaction date
Purchase
Price
138.78
Quantity 58,596 -13.2%
Value US$3,660,196
Cheruvu Pavan Principal Executive Officer Executive Director
Transaction date
Purchase
Price
194.92
Quantity 37,969 +45.7%
Value US$1,331,093
3.4
Pande Atul Non-Executive Director
Transaction date
Purchase
Price
2.73
Quantity 10,000 +74.8%
Value US$27,290
3.4
Pande Atul Non-Executive Director
Transaction date
Purchase
Price
1.78
Quantity 10,000 +296.7%
Value US$17,844
1.8
Roivant Sciences Ltd. Large shareholder
Transaction date
Purchase
Price
3.75
Quantity 5,333,333 +40.3%
Value US$19,999,999
3.4
Pande Atul
Transaction date
Purchase
Price
5.22
Quantity 3,370 +inf%
Value US$17,595
Cheruvu Pavan Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.21
Quantity 7,500 +inf%
Value US$39,075
1.8
Roivant Sciences Ltd. Large shareholder
Transaction date
Purchase
Price
1.50
Quantity 6,666,667 +6.7%
Value US$10,000,000
1.5
Machado Patrick Large shareholder
Transaction date
Purchase
Price
1.50
Quantity 6,666,667 +6.7%
Value US$10,000,000
Dexxon Holdings Ltd. Large shareholder
Transaction date
Purchase
Price
1.50
Quantity 6,666,667 +6.7%
Value US$10,000,000
QVT Associates GP LLC Large shareholder
Transaction date
Purchase
Price
1.50
Quantity 6,666,667 +6.7%
Value US$10,000,000
3.2
SVF Investments (UK) Ltd Large shareholder
Transaction date
Purchase
Price
1.50
Quantity 6,666,667 +6.7%
Value US$10,000,000
2.4
Lo Andrew Large shareholder
Transaction date
Purchase
Price
1.50
Quantity 6,666,667 +6.7%
Value US$10,000,000
Roivant Sciences Ltd. Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
SVF Investments (UK) Ltd Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
VIKING GLOBAL PERFORMANCE LLC Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
Dexxon Holdings Ltd. Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
VIKING GLOBAL INVESTORS LP Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
Lo Andrew Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
Machado Patrick Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
QVT Associates GP LLC Large shareholder
Transaction date
Purchase
Price
1.00
Quantity 10,000,000 +11.2%
Value US$10,000,000
Bickerstaff George Non-Executive Director
Transaction date
Purchase
Price
2.07
Quantity 25,000 +100.0%
Value US$51,750
SVF Investments (UK) Ltd Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
Roivant Sciences Ltd. Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
Dexxon Holdings Ltd. Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
Lo Andrew Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
VIKING GLOBAL PERFORMANCE LLC Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
QVT Associates GP LLC Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
Machado Patrick Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
VIKING GLOBAL INVESTORS LP Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 14,285,714 +19.0%
Value US$25,000,000
Bickerstaff George
Transaction date
Purchase
Price
1.50
Quantity 25,000 +inf%
Value US$37,425
Hung David Principal Executive Officer Executive Director
Transaction date
Purchase
Price
18.54
Quantity 539,375 +inf%
Value US$10,000,012
FALBERG KATHRYN E
Transaction date
Purchase
Price
18.54
Quantity 53,937 +inf%
Value US$999,992
VERNON W ANTHONY
Transaction date
Purchase
Price
18.54
Quantity 53,937 +inf%
Value US$999,992
Altmeyer Mark Pres&Chief Commercial Officer Officer
Transaction date
Purchase
Price
11.14
Quantity 2,300 +inf%
Value US$25,622
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-24 2021-03-23 B Purchase
Cheruvu Pavan

Chief Executive Officer

Executive Director
10,237 +38.6%
318.60
US$3,746,058 		10,237 +38.6% 318.60 US$3,746,058
2020-11-25 2020-11-24 B Purchase
3.4
Pande Atul
Non-Executive Director
58,596 -13.2%
138.78
US$3,660,196 		58,596 -13.2% 138.78 US$3,660,196
2020-07-10 2020-07-08 B Purchase
Cheruvu Pavan

Principal Executive Officer

Executive Director
37,969 +45.7%
194.92
US$1,331,093 		37,969 +45.7% 194.92 US$1,331,093
2020-07-10 2020-07-08 B Purchase
3.4
Pande Atul
Non-Executive Director
10,000 +74.8%
2.73
US$27,290 		10,000 +74.8% 2.73 US$27,290
2020-03-18 2020-03-16 B Purchase
3.4
Pande Atul
Non-Executive Director
10,000 +296.7%
1.78
US$17,844 		10,000 +296.7% 1.78 US$17,844
2020-02-27 2020-02-24 B Purchase
1.8
Roivant Sciences Ltd.
Large shareholder
5,333,333 +40.3%
3.75
US$19,999,999 		5,333,333 +40.3% 3.75 US$19,999,999
2019-06-17 2019-06-14 B Purchase
3.4
Pande Atul
3,370 +inf%
5.22
US$17,595 		3,370 +inf% 5.22 US$17,595
2019-06-17 2019-06-14 B Purchase
Cheruvu Pavan

Chief Executive Officer

Executive Director
7,500 +inf%
5.21
US$39,075 		7,500 +inf% 5.21 US$39,075
2019-03-19 2019-03-18 B Purchase
1.8
Roivant Sciences Ltd.
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2019-03-19 2019-03-18 B Purchase
1.5
Machado Patrick
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2019-03-19 2019-03-18 B Purchase
Dexxon Holdings Ltd.
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2019-03-19 2019-03-18 B Purchase
QVT Associates GP LLC
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2019-03-19 2019-03-18 B Purchase
3.2
SVF Investments (UK) Ltd
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2019-03-19 2019-03-18 B Purchase
2.4
Lo Andrew
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2019-03-19 2019-03-18 B Purchase
3.2
VIKING GLOBAL INVESTORS LP
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2019-03-19 2019-03-18 B Purchase
2.0
VIKING GLOBAL PERFORMANCE LLC
Large shareholder
6,666,667 +6.7%
1.50
US$10,000,000 		6,666,667 +6.7% 1.50 US$10,000,000
2018-12-20 2018-12-18 B Purchase Roivant Sciences Ltd. Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-12-20 2018-12-18 B Purchase SVF Investments (UK) Ltd Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-12-20 2018-12-18 B Purchase VIKING GLOBAL PERFORMANCE LLC Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-12-20 2018-12-18 B Purchase Dexxon Holdings Ltd. Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-12-20 2018-12-18 B Purchase VIKING GLOBAL INVESTORS LP Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-12-20 2018-12-18 B Purchase Lo Andrew Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-12-20 2018-12-18 B Purchase Machado Patrick Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-12-20 2018-12-18 B Purchase QVT Associates GP LLC Large shareholder
10,000,000 +11.2%
1.00
US$10,000,000 		10,000,000 +11.2% 1.00 US$10,000,000
2018-08-13 2018-08-09 B Purchase Bickerstaff George Non-Executive Director
25,000 +100.0%
2.07
US$51,750 		25,000 +100.0% 2.07 US$51,750
2018-06-07 2018-06-05 B Purchase SVF Investments (UK) Ltd Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-06-07 2018-06-05 B Purchase Roivant Sciences Ltd. Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-06-07 2018-06-05 B Purchase Dexxon Holdings Ltd. Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-06-07 2018-06-05 B Purchase Lo Andrew Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-06-07 2018-06-05 B Purchase VIKING GLOBAL PERFORMANCE LLC Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-06-07 2018-06-05 B Purchase QVT Associates GP LLC Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-06-07 2018-06-05 B Purchase Machado Patrick Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-06-07 2018-06-05 B Purchase VIKING GLOBAL INVESTORS LP Large shareholder
14,285,714 +19.0%
1.75
US$25,000,000 		14,285,714 +19.0% 1.75 US$25,000,000
2018-03-01 2018-02-27 B Purchase Bickerstaff George
25,000 +inf%
1.50
US$37,425 		25,000 +inf% 1.50 US$37,425
2017-04-19 2017-04-17 B Purchase Hung David

Principal Executive Officer

Executive Director
539,375 +inf%
18.54
US$10,000,012 		539,375 +inf% 18.54 US$10,000,012
2017-04-19 2017-04-17 B Purchase FALBERG KATHRYN E
53,937 +inf%
18.54
US$999,992 		53,937 +inf% 18.54 US$999,992
2017-04-19 2017-04-17 B Purchase VERNON W ANTHONY
53,937 +inf%
18.54
US$999,992 		53,937 +inf% 18.54 US$999,992
2016-03-14 2016-03-10 B Purchase Altmeyer Mark

Pres&Chief Commercial Officer

Officer
2,300 +inf%
11.14
US$25,622 		2,300 +inf% 11.14 US$25,622
Explore more

More insider trading research around Axovant Gene Therapies Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America